Prognostic value of lesion dissemination in doxorubicin, bleomycin, vinblastine, and dacarbazine‐treated, interimPET‐negative classical Hodgkin Lymphoma patients: A radio‐genomic study-Reference-Cited by-同舟云学术

Prognostic value of lesion dissemination in doxorubicin, bleomycin, vinblastine, and dacarbazine‐treated, interimPET‐negative classical Hodgkin Lymphoma patients: A radio‐genomic study

Published:2022-05-30 Issue:4 Volume:40 Page:645-657
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Durmo Rexhep¹²,Donati Benedetta³,Rebaud Louis⁴⁵,Cottereau Anne Segolene⁶,Ruffini Alessia⁷,Nizzoli Maria Elena⁷,Ciavarella Sabino⁸,Vegliante Maria Carmela⁸^ORCID,Nioche Christophe⁴,Meignan Michel⁹,Merli Francesco⁷,Versari Annibale¹,Ciarrocchi Alessia³^ORCID,Buvat Irene⁴,Luminari Stefano⁷¹⁰

Affiliation:

1. Nuclear Medicine Unit Azienda USL‐IRCCS Reggio Emilia Italy

2. PhD Program in Clinical and Experimental Medicine (CEM) University of Modena and Reggio Emilia Modena Italy

3. Translational Research Laboratory Azienda USL‐IRCCS Reggio Emilia Italy

4. Laboratoire d’Imagerie Translationnelle en Oncologie Institut Curie, U1288 Inserm, PSL Orsay France

5. Siemens Healthineers Saint‐Denis France

6. Department of Nuclear Medicine Cochin Hospital, AP‐HP, Université de Paris Paris France

7. Hematology Unit Azienda USL‐IRCCS Reggio Emilia Italy

8. Hematology and Cell Therapy Unit IRCCS‐Istituto Tumori 'Giovanni Paolo II' Bari Italy

9. Lysa Imaging Henri Mondor University Hospital, AP‐HP, University Paris East Creteil France

10. Surgical, Medical and Dental Department of Morphological Sciences Related to Transplant, Oncology and Regenerative Medicine University of Modena and Reggio Emilia Reggio Emilia Italy

Funder

Associazione Italiana per la Ricerca sul Cancro

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.3025

Reference38 articles.

1. Epidemiology and etiology of Hodgkin's lymphoma

2. ABVD versus BEACOPP for Hodgkin's Lymphoma When High-Dose Salvage Is Planned

3. Long-Term Results of the HD2000 Trial Comparing ABVD Versus BEACOPP Versus COPP-EBV-CAD in Untreated Patients With Advanced Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi

4. Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Impact of Serum β2-Microglobulin Levels in Hodgkin Lymphoma Treated with ABVD or Equivalent Regimens: A Comprehensive Analysis of 915 Patients;Cancers;2024-01-05

2. Metabolic tumor volume predicts outcome in patients with advanced stage follicular lymphoma from the RELEVANCE trial;Annals of Oncology;2024-01

3. Prognostic Value of Baseline Tumor Burden and Tumor Dissemination Extracted From 18F-FDG PET/CT in a Cohort of Adult Patients With Early or Advanced Hodgkin Lymphoma;Clinical Nuclear Medicine;2023-11-24

4. A different perspective on PET/CT before treatment in patients with Hodgkin lymphoma: importance of volumetric and dissemination parameters;Annals of Hematology;2023-11-15

5. Prognostic model using 18F-FDG PET radiomics predicts progression-free survival in relapsed/refractory Hodgkin lymphoma;Blood Advances;2023-11-02